Intrinsic Value of S&P & Nasdaq Contact Us

Aridis Pharmaceuticals, Inc. ARDS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ARDS

Aridis Pharmaceuticals, Inc. (ARDS) has a market capitalization of $8.92K and trades at $0.00. The 52-week range is 0.0001-0.05.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.64.

The stock has a beta of -26.04, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.05
Volume12.62K
Avg Volume (30D)5.03K
Market Cap$8.92K
Beta (1Y)-26.04
Company
IPO Date2018-08-14
Employees37
CEOVu L. Truong
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS0403341045
CUSIP040334104
Income (Latest Year)
EBITDA$-29.51M
Operating Income$-29.99M
Net Income$-30.75M
EPS$-1.64
EPS Diluted$-1.64
Shares Outstanding$18.78M
Balance Sheet (Latest Year)
Total Assets$14.7M
Current Assets$11.63M
Cash & ST Investments$4.88M
Total Liabilities$38.93M
Total Debt$6.13M
Net Debt$1.25M
Total Equity$-24.23M
Debt / Equity-0.25
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message